Genocea Biosciences, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
6.48
|
|
Average Rating
|
4.60
|
|
# Strong Buys
|
3
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-06-30
|
-0.18
|
0.00
|
0.18
|
100.00%
|
|
2022-03-31
|
-0.18
|
-0.22
|
-0.04
|
-22.22%
|
|
2021-12-31
|
-0.20
|
-0.19
|
0.01
|
5.00%
|
|
2021-09-30
|
-0.20
|
-0.05
|
0.15
|
75.00%
|
|
2021-06-30
|
-0.18
|
-0.06
|
0.12
|
66.67%
|
|
2021-03-31
|
-0.20
|
-0.17
|
0.03
|
15.00%
|
|
2020-12-31
|
-0.21
|
-0.23
|
-0.02
|
-9.52%
|
|
2020-09-30
|
-0.24
|
-0.08
|
0.16
|
66.67%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.22
|
|
2021-12-31
|
-0.47
|
|
2020-12-31
|
-1.16
|
|
2019-12-31
|
-2.24
|
|
2018-12-31
|
-2.77
|
|
2017-12-31
|
-12.48
|
|
2016-12-31
|
-1.75
|
|
2015-12-31
|
-1.81
|
|
2014-12-31
|
-10.55
|
|
2013-12-31
|
-3.76
|